Prestwick3_000495

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

12 Suppliers, 6 USDMF, 1 CEP/COS, 1 EU WC, 3 NDC API, 5 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

11 Dossiers, 10 FDA Orange Book, 1 Canada

DRUG PRODUCT COMPOSITION

CREAM;VAGINAL - 0.4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUPPOSITORY;VAGINAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;VAGINAL - 0.8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;VAGINAL - 0.8%

RELATED EXCIPIENT COMPANIES

Suppliers, 8 BASF, 7 Seppic, 4 Gangwal Chemicals, 3 Nanjing Well Pharmaceutical, 2 Actylis, 1 Jai Radhe Sales, 1 Nanjing Bold Chemical, 1 Finar

EXCIPIENTS BY APPLICATIONS

15 Solubilizers, 11 Topical, 6 Parenteral, 4 Emulsifying Agents, 3 Surfactant & Foaming Agents, 3 Thickeners and Stabilizers, 3 Film Formers & Plasticizers, 2 Direct Compression, 1 Fillers, Diluents & Binders, 1 Rheology Modifiers, 1 API Stability Enhancers, 1 Lubricants & Glidants, 1 Granulation, 1 Co-Processed Excipients

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions, 1 Finished Drug Prices

MARKET PLACE

6 APIs

6 APIs

ANALYTICAL SOLUTION(s)

2 EDQM Standards, 1 USP Standards, 1 Other Ref. Standards

Approved Drug Products containing Prestwick3_000495 listed in the FDA Orange Book. Original Data : FDA Website

Prestwick3_000495

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

12 Suppliers

6 USDMF

1 CEP/COS

1 EU WC

3 NDC API

5 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Forms

11 Dossiers

10 FDA Orange Book

1 Canada

DRUG PRODUCT COMPOSITION

CREAM;VAGINAL - 0.4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUPPOSITORY;VAGINAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;VAGINAL - 0.8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;VAGINAL - 0.8%

RELATED EXCIPIENT COMPANIES

Suppliers

8 BASF

7 Seppic

4 Gangwal Chemicals

3 Nanjing Well Pharmaceutical

2 Actylis

1 Jai Radhe Sales

1 Nanjing Bold Chemical

1 Finar

EXCIPIENTS BY APPLICATIONS

15 Solubilizers

11 Topical

6 Parenteral

4 Emulsifying Agents

3 Surfactant & Foaming Agents

3 Thickeners and Stabilizers

3 Film Formers & Plasticizers

2 Direct Compression

1 Fillers, Diluents & Binders

1 Rheology Modifiers

1 API Stability Enhancers

1 Lubricants & Glidants

1 Granulation

1 Co-Processed Excipients

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions

1 Finished Drug Prices

MARKET PLACE

6 APIs

ANALYTICAL SOLUTION(s)

2 EDQM Standards

1 USP Standards

1 Other Ref. Standards

CREAM;VAGINAL

0.8%

2004-10-01

21735

TERCONAZOLE

RX

Yes

BX

CREAM;VAGINAL

0.4%

2005-02-18

76712

TERCONAZOLE

RX

No

AB

SUPPOSITORY;VAGINAL

80MG

2006-07-12

76850

CREAM;VAGINAL - 0.4% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SUPPOSITORY;VAGINAL - 80MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM;VAGINAL - 0.8% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

0.4% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

80MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

0.8% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons